🇺🇸 FDA
Patent

US 8952169

N-substituted benzamides and methods of use thereof

granted A61KA61K31/18A61K31/397

Quick answer

US patent 8952169 (N-substituted benzamides and methods of use thereof) held by Xenon Pharmaceuticals Inc. expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
43
CPC classes
A61K, A61K31/18, A61K31/397, A61K31/40, A61K31/41